Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | NQO1 | P15559 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | TDO2 | P48775 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.45 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.45 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15476760 | 1.00 | MAPT (0.60) | MAPTHPRT1ALDH1A1KDM4EMAPK1 | |
| SCHEMBL278576 | 0.90 | MAPT (0.67) | MAPTALDH1A1KDM4EMAPK1SMN1; SMN2 | |
| SCHEMBL30380487 | 0.90 | MAPT (0.67) | MAPTALDH1A1KDM4EMAPK1SMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL11476305 | 0.88 | MAPT (0.64) | MAPTALDH1A1KDM4EMAPK1SMN1; SMN2 | |
| SCHEMBL9765549 | 0.86 | MAOA (0.54) | MAPTALDH1A1KDM4EMAPK1SMN1; SMN2 | |
| Formaldehyde SCHEMBL28780252 | 0.85 | MAPT (0.60) | MAPTALDH1A1KDM4EMAPK1SMN1; SMN2 | |
| Cyanide SCHEMBL29227829 | 0.85 | MAPT (0.60) | MAPTALDH1A1KDM4EMAPK1SMN1; SMN2 | |
| SCHEMBL16641096 | 0.83 | ALDH1A1 (0.50) | MAPTALDH1A1KDM4EMAPK1SMN1; SMN2 | |
| SCHEMBL11505219 | 0.82 | HTT (0.48) | MAPTHPRT1ALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL27873366 | 0.81 | MAPT (0.52) | MAPTHPRT1ALDH1A1KDM4EMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042726-A1 | ENCODED DESIGN INTEGRATED SYNTHESIS OF NUCLEIC ACIDS, AND PHOSPHOLIPIDS, AND RELATED PHARMACEUTICAL PRODUCTS | SCHAPER CHARLES (US) | 2026-02-12 | — | — | US | disclosed |
| US-12473247-B2 | Encoded design integrated synthesis of nucleic acids, and phospholipids, and related pharmaceutical products | Schaper, Charles (US) | 2025-11-18 | — | — | US | disclosed |
| US-20250074853-A1 | ENCODED DESIGN INTEGRATED SYNTHESIS OF NUCLEIC ACIDS, AND PHOSPHOLIPIDS, AND RELATED PHARMACEUTICAL PRODUCTS | SCHAPER CHARLES (US) | 2025-03-06 | — | — | US | disclosed |
| US-12195423-B1 | Encoded design integrated synthesis of nucleic acids, and phospholipids, and related pharmaceutical products | SCHAPER CHARLES (US) | 2025-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12195423-B1 | Encoded design integrated synthesis of nucleic acids, and phospholipids, and related pharmaceutical products | POLRMT, TARBP1, PHOSPHO1 | MAPT 3753/4885HPRT1 478/4885ALDH1A1 4705/4885 |
| US-20250074853-A1 | ENCODED DESIGN INTEGRATED SYNTHESIS OF NUCLEIC ACIDS, AND PHOSPHOLIPIDS, AND RELATED PHARMACEUTICAL PRODUCTS | POLRMT, TARBP1, PHOSPHO1 | MAPT 3753/4885HPRT1 478/4885ALDH1A1 4705/4885 |
| US-12473247-B2 | Encoded design integrated synthesis of nucleic acids, and phospholipids, and related pharmaceutical products | POLRMT, TARBP1, PHOSPHO1 | MAPT 3753/4885HPRT1 478/4885ALDH1A1 4705/4885 |
| US-20260042726-A1 | ENCODED DESIGN INTEGRATED SYNTHESIS OF NUCLEIC ACIDS, AND PHOSPHOLIPIDS, AND RELATED PHARMACEUTICAL PRODUCTS | POLRMT, POLM, PHOSPHO1 | MAPT 4593/4885HPRT1 1907/4885ALDH1A1 3743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.